The variant should be treated as pathogenic, and cancer risk-reducing surgery should be recommended

The variant should be automatically reclassified to likely benign if it is rare in the general population

The variant should be reported, but clinical decisions should be based on personal and family history until further evidence clarifies its significance

The variant should be ignored, as it is most likely benign and worth no further attention